ArticleTherapeutic advances in neurological disorders2012

Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis.

Peter Rieckmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.